CRD-33

N/A

Report date: 2025/01/26 18:07:48

Base Information

Drug NameCRD-33
Drug Alias Namespecific cancer cell targeting monoclonal antibody (CRD Pharma)CRD-33
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCRD Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCRD Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A